20197-44-8

Downstream Products

• 20881-87-2 Methyl 4-amino-4,6-dideoxy-α-D-mannopyranoside 
• 15856-45-8 methyl 4-acetamido-4,6-dideoxy-α-D-mannopyranoside 
• 101072-27-9 Methyl 2,3-di-O-acetyl-4,6-dideoxy-4-<(1S)-(1,4/5,6)-4,5,6-triacetoxy-3-(benzoyloxymethyl)-2-cyclohexen-1-ylamino>-α-D-mannopyranoside 
• 141316-50-9 Methyl 4,6-dideoxy-4-<(1S)-(1,4/5,6)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-ylamino>-α-D-mannopyranoside 

Relevant academic research and scientific papers

Tallysomycin, a new antitumor antibiotic complex related to bleomycin. II. Structure determination of tallysomycins A and B

The structures of tallysomycins A and B, two major components of a new antitumor antibiotic complex, have been determined. They are glycopeptide antibiotics structurally related to bleomycin: four amino acid moieties and a disaccharide fragment which are the constituents of bleomycin molecule are also present in the tallysomycins. Tallysomycins A and B contain two new amino acids and a unique amino sugar, 4-amino-4,6-dideoxy-L-talose, which have not been hitherto found in the phleomycin-bleomycin group of antibiotics. In addition tallysomycin A has an additional amino acid, L-β-lysine, and thus a longer peptide chain than bleomycin or tallysomycin B. Tallysomycins A and B have the same terminal amine moiety, spermidine.